APA (7th ed.) Citation

MJ, L., C, L., D, S., F, C., S, S., K, T., . . . DC, I. (2025). Combined haptoglobin and hemopexin therapy for the treatment of cardiopulmonary dysfunction in sickle cell disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 192, 118595. https://doi.org/10.1016/j.biopha.2025.118595

Chicago Style (17th ed.) Citation

MJ, Lucero, et al. "Combined Haptoglobin and Hemopexin Therapy for the Treatment of Cardiopulmonary Dysfunction in Sickle Cell Disease." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 192 (2025): 118595. https://doi.org/10.1016/j.biopha.2025.118595.

MLA (9th ed.) Citation

MJ, Lucero, et al. "Combined Haptoglobin and Hemopexin Therapy for the Treatment of Cardiopulmonary Dysfunction in Sickle Cell Disease." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 192, 2025, p. 118595, https://doi.org/10.1016/j.biopha.2025.118595.